Abrupt Relapse of ALK-Positive Lymphoma after Discontinuation of Crizotinib

被引：62
|
作者：
Gambacorti-Passerini, Carlo [1 ]
Mussolin, Lara [2 ]
Brugieres, Laurence [3 ]
机构：
[1] Univ Milano Bicocca, Monza, Italy
[2] Univ Padua, Padua, Italy
[3] Gustave Roussy Canc Campus, Villejuif, France
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2016年 / 374卷 / 01期
关键词：
LARGE-CELL LYMPHOMA;
D O I：
10.1056/NEJMc1511045
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：95 / 96
页数：2
相关论文
共 50 条
  • [31] Rapid Postoperative Relapse in ALK-Positive Locally Advanced NSCLC Patient with Complete Pathological Response to Neoadjuvant Crizotinib
    Zhang, Chao
    Wu, Yi-Long
    Zhong, Wen-Zhao
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : E234 - E236
  • [32] Differential crizotinib response duration among ALK fusion variants in ALK-positive NSCLC
    Yoshida, T.
    Oya, Y.
    Tanaka, K.
    Shimizu, J.
    Horio, Y.
    Hida, T.
    Yatabe, Y.
    ANNALS OF ONCOLOGY, 2015, 26 : 139 - 139
  • [33] Anaplastic large cell lymphoma, ALK-positive
    Ferreri, Andres J. M.
    Govi, Silvia
    Pileri, Stefano A.
    Savage, Kerry J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 83 (02) : 293 - 302
  • [34] Systemic ALK-positive Lymphoma with Cutaneous Findings
    Xie, Daniel
    Jung, Jae
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB91 - AB91
  • [35] ALK-positive desmoplastic Spitz naevus in a patient with corresponding ALK-positive anaplastic large cell lymphoma
    Nguyen, J.
    Huang, A.
    Fleming, J.
    MacGregor, D.
    Wilks, D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S13 - S13
  • [36] Brigatinib After Progression From Alectinib or Crizotinib: Paving the Way for Treatment Sequencing of ALK Inhibitors in ALK-Positive NSCLC
    Song, Lianxi
    Xu, Qinqin
    Lizaso, Analyn
    Zhang, Yongchang
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : 349 - 351
  • [37] The efficacy of crizotinib in patients with ALK-positive nonsmall cell lung cancer
    Pender, Alexandra
    Popat, Sanjay
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2015, 9 (03) : 97 - 104
  • [38] Induction of autophagy contributes to crizotinib resistance in ALK-positive lung cancer
    Ji, Cheng
    Zhang, Li
    Cheng, Yan
    Patel, Raj
    Wu, Hao
    Zhang, Yi
    Wang, Mian
    Ji, Shundong
    Belani, Chandra P.
    Yang, Jin-Ming
    Ren, Xingcong
    CANCER BIOLOGY & THERAPY, 2014, 15 (05) : 570 - 577
  • [39] Expanding opportunities for crizotinib resistance in ALK-positive lung cancer patients
    Ilie, Marius
    Hofman, Paul
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 (02) : 203 - 205
  • [40] Crizotinib Outcomes in ALK-Positive Advanced NSCLC Patients with Brain Metastases
    Davis, Keith L.
    Kaye, James A.
    Iyer, Shrividya
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S376 - S377
12345